AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases.
It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation.
The company also provides StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves.
It serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally.
The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013.
Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.
Country | United States |
IPO Date | Oct 1, 2020 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 279 |
CEO | Steven S. Williamson |
Contact Details
Address: 700 Chesapeake Drive Redwood City, California United States | |
Website | https://pulmonx.com |
Stock Details
Ticker Symbol | LUNG |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001127537 |
CUSIP Number | 745848101 |
ISIN Number | US7458481014 |
Employer ID | 00-0000000 |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
Steven S. Williamson | Chief Executive Officer, President & Director |
Lisa Paul | Chief People Officer |
Mehul Joshi | Chief Financial Officer |
David A. Lehman J.D. | General Counsel & Secretary |
Geoffrey Beran Rose | Chief Commercial Officer |
John B. McKune | Vice President & Corporate Controller |
Jérôme Erath | Senior Vice President & GM of Europe Middle-East & Africa |
Marcee M. Maroney | Vice President of Marketing |
Sarah Huber | Vice President of Sales (U.S.) |
Sri Radhakrishnan | Chief Technical Officer |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 04, 2024 | 4 | Filing |
Dec 04, 2024 | 4 | Filing |
Nov 26, 2024 | 4 | Filing |
Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 08, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 01, 2024 | 10-Q | Quarterly Report |
Oct 30, 2024 | 8-K | Current Report |
Oct 21, 2024 | 4 | Filing |
Sep 18, 2024 | 4 | Filing |